>>

>>

>>

>>

病原体与感染

>>

>

Recombinant Human anti-COVID-19/SARS-CoV-2 RBD Monoclonal Antibody

Recombinant Human anti-COVID-19/SARS-CoV-2 RBD Monoclonal Antibody

Recombinant Human anti-COVID-19/SARS-CoV-2 RBD Monoclonal Antibody

产品编号

MAV101

别名

SARS-CoV-2 RBD antibody, 2019-nCoV, Coronavirus

规格

100ul
500ul

DATASHEET COA

立即询价加入询价列表大包装定制

产品介绍

Alias	SARS-CoV-2 RBD antibody, 2019-nCoV, Coronavirus
Catalog Number	MAV101
Product Description	The product is specific for SARS-CoV-2 Spike Protein S1 subunit (Cat.#: COV362)and its RBD domain (Cat.#: COV363), and can inhibit the interaction between SARS-CoV-2 Spike Protein RBD and ACE2. Cat#. MAV101 and Cat#.MAV102 are antibody pair which is verified for ELISA.
Molecular Name	COVID-19
Species	COVID-19
Host	Human
Size	100ul, 500ul
Clonity	Recombinant mAb
Clone Number	1G6
Concentration	1mg/ml
Antibody Isotype	IgG1
Formulation	0.01M PBS, pH 7.4
Background	A novel severe acute respiratory syndrome (SARS)-like coronavirus (SARS-CoV-2) recently emerged and is rapidly spreading in humans, causing COVID-19. A key to tackling this pandemic is to understand the receptor recognition mechanism of the virus, which regulates its infectivity, pathogenesis and host range. SARS-CoV-2 and SARS-CoV recognize the same receptor—angiotensin-converting enzyme 2 (ACE2)—in humans. Researchers determined the crystal structure of the receptor-binding domain (RBD) of the spike protein of SARS-CoV-2 (engineered to facilitate crystallization) in complex with ACE2. In comparison with the SARS-CoV RBD, an ACE2-binding ridge in SARS-CoV-2 RBD has a more compact conformation; moreover, several residue changes in the SARS-CoV-2 RBD stabilize two virus-binding hotspots at the RBD–ACE2 interface. These structural features of SARS-CoV-2 RBD increase its ACE2-binding affinity. Additionally, we show that RaTG13, a bat coronavirus that is closely related to SARS-CoV-2, also uses human ACE2 as its receptor.
Immunogen	Native virus
Application	ELISA, POCT, Neu, Standard
Biological Activity	IC50 = 2.8 ng/mL using SARS-CoV-2 Inhibitor screening Kit
Cross-reactivity	React with SARS-CoV-2(COVID-19) S1-RBD protein. Do not react with other SARS-CoV-2 subunits.
Storage Condition	This product can be stored at 2℃-8℃ for one month. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Avoid repeated freeze-thaw cycles.
Product Declaration	This product is for research use only and must not be used directly on humans or for injection.

推荐产品

400-621-6806
3599163699
周一至周五 9:00-18:00
0